![Ann Meulemans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann Meulemans is the founder of OCTIMET Oncology NV, founded in 2016.
Dr. Meulemans is currently the Director at Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen since 2020.
Formerly, Chief Executive Officer at AbolerIS Pharma from 2020 to 2025 and Vice President at Movetis NV from 2007 to 2009.
Education includes a graduate and doctorate from the University of Antwerp.
| Bedrijven | Functie | Begin |
|---|---|---|
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen
 Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Miscellaneous Commercial ServicesCommercial Services Operates as a organization for scientific research | Directeur/Bestuurslid | 15-05-2020 |
AbolerIS Pharma
 AbolerIS Pharma Pharmaceuticals: MajorHealth Technology Develops novel and unique therapies | Algemeen Directeur | 01-11-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
OCTIMET Oncology NV
 OCTIMET Oncology NV BiotechnologyHealth Technology Develops discovery stage molecules by employing innovative patient selection | Oprichter | - |
Movetis NV
 Movetis NV Pharmaceuticals: GenericHealth Technology Specializes in developing compounds for gastrointestinal disorders | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
Movetis NV
Movetis NV Pharmaceuticals: GenericHealth Technology Specializes in developing compounds for gastrointestinal disorders | Health Technology |
University of Antwerp
 University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OCTIMET Oncology NV
OCTIMET Oncology NV BiotechnologyHealth Technology Develops discovery stage molecules by employing innovative patient selection | Health Technology |
AbolerIS Pharma
AbolerIS Pharma Pharmaceuticals: MajorHealth Technology Develops novel and unique therapies | Health Technology |
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Miscellaneous Commercial ServicesCommercial Services Operates as a organization for scientific research | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
